Cite
HARVARD Citation
Klemen, N. et al. (2019). Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma. Journal for immunotherapy of cancer. 7 (1), p. . [Online].